INTELLIGENT BIO SOLUTIONS INC. Capital Expenditures
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Capital Expenditures of $125.73 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-19.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-19
- INTELLIGENT BIO SOLUTIONS INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $0.00.
- INTELLIGENT BIO SOLUTIONS INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was -$12.90K.
- INTELLIGENT BIO SOLUTIONS INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $68.23K.
- INTELLIGENT BIO SOLUTIONS INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $70.40K.
- INTELLIGENT BIO SOLUTIONS INC. payments to acquire property, plant, and equipment for fiscal 2026 was $125.73K, a 45.77% decline from fiscal 2025.
- INTELLIGENT BIO SOLUTIONS INC. payments to acquire property, plant, and equipment for fiscal 2025 was $231.84K, a 4.70% increase from fiscal 2024.
- INTELLIGENT BIO SOLUTIONS INC. payments to acquire property, plant, and equipment for fiscal 2024 was $221.43K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | -$12.90K derived: sum of 2 quarters · filed 2026-08-19 | $55.33K derived: sum of 3 quarters · filed 2026-08-19 | $125.73K 10-K · filed 2026-08-19 | |
| 2026-03-31 | -$12.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | $55.33K derived: sum of 2 quarters · filed 2026-05-13 | $125.73K 10-Q · filed 2026-05-13 | ||
| 2025-12-31 | $68.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12 | $138.63K 10-Q · filed 2026-02-12 | |||
| 2025-09-30 | $70.40K 10-Q · filed 2025-11-12 | ||||
| 2025-06-30 | $231.84K 10-K · filed 2026-08-19 | ||||
| 2024-12-31 | $8.94K 10-Q · filed 2026-02-12 | ||||
| 2024-06-30 | $221.43K 10-K · filed 2025-08-15 | $5.37K 10-K · filed 2024-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |